Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03897088
What this trial is testing

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries Limited 231
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833307
What this trial is testing

The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis

Who this might be right for
Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT03316781
What this trial is testing

Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Shanghai Henlius Biotech 262
Large-scale testing (Phase 3)Study completedNCT01232283
What this trial is testing

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Amgen 413
Testing effectiveness (Phase 2)Study completedNCT01899729
What this trial is testing

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Idera Pharmaceuticals, Inc. 46
Early research (Phase 1)Study completedNCT05342428
What this trial is testing

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Hangzhou Highlightll Pharmaceutical Co., Ltd 73
Large-scale testing (Phase 3)Study completedNCT02850965
What this trial is testing

Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 318
Not applicableStudy completedNCT03982394
What this trial is testing

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
AbbVie 2,759
Post-approval studies (Phase 4)Study completedNCT00302445
What this trial is testing

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Derm Research, PLLC 20
Post-approval studies (Phase 4)Study completedNCT00287118
What this trial is testing

A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Candidates for Systemic Therapy for PsoriasisPsoriasis
Merck KGaA, Darmstadt, Germany 189
Testing effectiveness (Phase 2)Study completedNCT03025542
What this trial is testing

Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 49
Large-scale testing (Phase 3)Study completedNCT02684370
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 560
Testing effectiveness (Phase 2)Study completedNCT00678210
What this trial is testing

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 197
Large-scale testing (Phase 3)Looking for participantsNCT07724366
What this trial is testing

A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT07474792
What this trial is testing

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT03624127
What this trial is testing

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 666
Large-scale testing (Phase 3)Study completedNCT03390101
What this trial is testing

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Biocad 213
Testing effectiveness (Phase 2)Study completedNCT05190419
What this trial is testing

Study to Assess the Efficacy and Safety of Orismilast in Psoriasis

Who this might be right for
PsoriasisSkin Diseases
UNION therapeutics 202
Testing effectiveness (Phase 2)Study completedNCT03858634
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Who this might be right for
Chronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more
Genentech, Inc. 58
Testing effectiveness (Phase 2)Looking for participantsNCT07251998
What this trial is testing

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 172
Next Page